摘要
目的观察复方苦参注射液联合化疗治疗肺癌的临床疗效。方法将141例病例分为对照组和综合组,其中综合组为除化疗方案及剂量与对照组相同外,在化疗同时加用复方苦参注射液20mL于生理盐水中,每日1次静滴。结果近期疗效综合组高于对照组(P<0.05)。两组治疗后毒性反应无明显差异(P>0.05)。结论复方苦参注射液确实能提高肺癌患者的化疗疗效。
[Objective] To observe the efiqcacy of compound therapy of Composite Radix Sophora Flavescentis Injection and chemotherapy on lung cancer. [Methods] 141 cases with lung cancer were divided into contrast and study group randomly. Compound therapy was administrated including Radix Sophora Flavescentis（20 mL in saline）. only chemotherapy was used in contrast group. [Results] In the efficacy, study group is better than contrast group （P 〈0.05）. There is no difference （P 〉0.05） in adverse reaction. [Conclusions] Composite Radix Sophora Flavescentis Injection can increase effect of chemotherapy in lung cancer.
出处
《中国现代医学杂志》
CAS
CSCD
北大核心
2006年第1期139-140,143,共3页
China Journal of Modern Medicine
关键词
复方苦参注射液
化疗
肺癌
Composite Radix Sophora Flavescentis Injection
chemotherapy
lung cancer
